What is the most recent earnings date for AVEO stock?
AVEO PHARMACEUTICALS INC (AVEO) last reported earnings on 11/7/2022.
AVEO PHARMACEUTICALS INC (AVEO) Earnings History & Surprises
NASDAQ:AVEO • US0535883070
Current stock price
15 USD
0 (0%)
At close:
15 USD
0 (0%)
After Hours:
AVEO Earnings overview
Past quarterly earnings results for AVEO PHARMACEUTICALS INC (AVEO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 13, 2023
- Period
- Q4 / 2022
- EPS Estimate
- -$0.05
- Revenue Estimate
- 36.075M
Last Reported
Most Recent- Release Date
- Nov 7, 2022
- Period
- Q3 / 2022
- EPS Reported
- -$0.09
- EPS Surprise
- 49.87%
- Revenue Surprise
- 1.03%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | -0.09 | -0.18 | 49.87% | 70.00% | 30.449M | 30.14M | 1.03% | 100.68% |
| Q2 2022 | -0.24 | -0.29 | 15.97% | 40.00% | 25.304M | 25.845M | -2.09% | 234.89% |
| Q1 2022 | -0.30 | -0.25 | -18.60% | 62.96% | 20.92M | 21.064M | -0.68% | 1,001.05% |
| Q4 2021 | -0.21 | -0.29 | 28.39% | 52.27% | 17.646M | 18.293M | -3.54% | 1,860.67% |
| Q3 2021 | -0.30 | -0.37 | 18.86% | 9.09% | 15.173M | 14.075M | 7.80% | 321.47% |
| Q2 2021 | -0.40 | -0.46 | 12.85% | 4.76% | 7.556M | 9.12M | -17.15% | 979.43% |
| Q1 2021 | -0.81 | -0.56 | -45.04% | -55.77% | 1.9M | 1.032M | 84.11% | 137.50% |
| Q4 2020 | -0.44 | -0.39 | -13.52% | - | 900K | 3.06M | -70.59% | - |
| Q3 2020 | -0.33 | -0.24 | -34.80% | - | 3.6M | 3.023M | 19.09% | - |
| Q2 2020 | -0.42 | -0.52 | 18.73% | - | 700K | 1.378M | -49.20% | - |
| Q1 2020 | -0.52 | -0.51 | -2.64% | - | 800K | 1.87M | -57.22% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
18.91%
Max EPS beat (4)
49.87%
Min EPS beat (4)
-18.60%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-1.32%
Max Revenue beat (4)
1.03%
Min Revenue beat (4)
-3.54%
Analysis
In the last 4 quarters, AVEO has beaten EPS estimates in 3 out of 4 releases
AVEO has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, AVEO has beaten the EPS estimates by 18.9% on average.
In the last 4 quarters, AVEO reported -1.3% below the revenue estimates on average.
Related analysis
AVEO PHARMACEUTICALS INC / AVEO Earnings FAQ
Did AVEO stock beat earnings estimates in the most recent quarter?
AVEO PHARMACEUTICALS INC (AVEO) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does AVEO PHARMACEUTICALS INC (AVEO) beat earnings estimates?
In the last 4 quarters, AVEO PHARMACEUTICALS INC (AVEO) has beaten EPS estimates in 3 out of 4 releases.